Showing results (181-190 of 279) with videos related to

Sort By:
Pageof 28
Leukemia Research|May 21, 1998
Chronic myelogenous leukemia: effect of interferon-alpha treatment on phagocytic activity and capacity of circulating neutrophilsS Kasimir-Bauer, H Ottinger, M Wuttke, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 1998
Simulation of 3D-treatment plans in head and neck tumors aided by matching of digitally reconstructed radiographs (DRR) and on-line distortion corrected simulator imagesF Lohr, O Schramm, P Schraube, et al.
Klinische Wochenschrift|December 4, 1989
[Sequential induction chemotherapy and radiation treatment of inoperable small cell bronchial cancer. Results of a prospective randomized study]J Schütte, N Niederle, W Eberhardt, et al.
Leukemia|May 1, 1994
Bcr-abl-positive and -negative clonogenic cells in CML patients undergoing long-term interferon treatmentU B Wandl, R Bützler, N Niederle, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
British Journal of Cancer|June 16, 2012
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative networkK Mross, C Dittrich, W E Aulitzky, et al.
Deutsche Medizinische Wochenschrift (1946)|February 7, 1998
[Comparison of stress echocardiography and radionuclide ventriculography in the diagnosis of cardiomyopathy in patients receiving chemotherapy for malignant diseases]R Leischik, E G Eising, M Katz, et al.
Oncology Research|January 1, 1997
Cellular determinants of resistance to indolocarbazole analogue 6-N-formylamino-12,13-dihydro-1,11-dihydroxy-13(beta-D-glucopyranosyl)- 5H-indolo[2,3-alpha]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), a novel potent topoisomerase I inhibitor, in multidrug-resistant human tumor cellsU Vanhoefer, W Voigt, R A Hilger, et al.
British Journal of Haematology|July 10, 2001
Estimating the relapse stage in chronic myeloid leukaemia patients after allogeneic stem cell transplantation by the amount of BCR-ABL fusion transcripts detected using a new real-time polymerase chain reaction methodA H Elmaagacli, A Freist, M Hahn, et al.
International Journal of Cancer|February 13, 1999
Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalitiesM Sarbia, M Stahl, U Fink, et al.
Pageof 28